Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · page 117 of 120
The slide compares efficacy in mutant vs wildtype models using bar charts for tumor growth inhibition and Kaplan-Meier curves for progression-free survival.
Conference presentation · before_after · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 2/2 paragraph 1/1 source-note 1/1 title 1/1
Components 5
bar-vertical line paragraph source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.